Oxford starts first study to reinfect recovered Covid-19 patients
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
SUNDAY, MAY 22, 2022
SUNDAY, MAY 22, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Oxford starts first study to reinfect recovered Covid-19 patients

Coronavirus chronicle

TBS Report
19 April, 2021, 12:10 pm
Last modified: 19 April, 2021, 01:48 pm

Related News

  • Dynamic zero-Covid approach: China's choice to safeguard lives, underpin economic growth
  • Covax calls for urgent action to close vaccine equity gap
  • Thousands of Covid-negative Beijing residents sent to quarantine
  • Shanghai inches towards Covid lockdown exit, Beijing plays defence
  • N Korea reports over 200,000 fever cases for 5th day amid Covid wave

Oxford starts first study to reinfect recovered Covid-19 patients

Researchers are looking for 64 healthy, previously Covid-infected volunteers from 18 to 30 years old to be studied under controlled, quarantined conditions for at least 17 days, the UK university said Monday

TBS Report
19 April, 2021, 12:10 pm
Last modified: 19 April, 2021, 01:48 pm
Photo: Collected
Photo: Collected

People who previously infected with Covid-19 will be deliberately reinfected in a first-of-its-kind trial at the University of Oxford that may shed light on how to develop more effective vaccines against the pathogen, reports Bloomberg. 

Researchers are looking for 64 healthy, previously Covid-infected volunteers from 18 to 30 years old to be studied under controlled, quarantined conditions for at least 17 days, the UK university said Monday. Participants will be infected with the original strain from Wuhan, China and followed for a year.

Initial data from the Oxford study should be available within several months, helping vaccine developers look at levels and types of immunity needed to prevent reinfection, and how long protection persists. Challenge trials, involving deliberate, supervised infections, are seen as particularly helpful for answering questions like these, because they allow scientists to scrutinize the details of how the body confronts the virus and vice versa.

While vaccines and previous infections provide some immune protection against the coronavirus, concerns and doubts remain about how long it lasts. A recent study indicated that as much as 10% of previously infected young adults were reinfected, underscoring the need for effective vaccines to prevent spread, and Pfizer Inc.'s chief executive officer has said that booster shots may be needed to maintain the immunity provided by the initial two doses of the company's shot.

The Oxford study "has the potential to transform our understanding by providing high-quality data on how our immune system responds to a second infection," said Shobana Balasingam, a research adviser at the Wellcome Trust, which is providing funds. The findings could "inform not just vaccine development but also research into the range of effective treatments that are also urgently needed."

One of the goals of the study is to determine how much virus, on average, it takes to infect someone who's had the virus earlier. In a second phase of the study, a different group of patients will be given that dose and studied for their immune responses, Oxford said.

The earliest volunteers in the world's first human challenge trial involving the coronavirus, conducted by Imperial College in London, left quarantine in late March. That trial, which intentionally infected people who hadn't previously had the virus, was backed by 33.6 million pounds ($46.3 million) of U.K. government funding.

Critics of challenge trials have pointed out the ethical dangers of infecting people without being sure of its long-term consequences. The Oxford researchers said that all those enrolled will be completely fit, well and recovered from their first Covid infection.

Participants who develop Covid symptoms will be treated with an antibody drug from Regeneron Pharmaceuticals Inc. that's been authorized by U.S. regulators, Oxford said. Subjects will only be discharged from the quarantine unit when they are no longer infected and not at risk of infecting others, according to the statement.

Top News / World+Biz

COVID-19 / Oxford / Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: Collected
    BSEC seeks explanation from Shakib Al Hasan on gold venture 
  • Court sends Haji Salim to jail rejecting bail plea
    Court sends Haji Salim to jail rejecting bail plea
  • VAT on sales of locally-produced APIs likely to go from FY23
    VAT on sales of locally-produced APIs likely to go from FY23

MOST VIEWED

  • A person in personal protective equipment (PPE) walks a dog at a resident community, as the second stage of a two-stage lockdown has been launched to curb the spread of the coronavirus disease (Covid-19) in Shanghai, China April 3, 2022. REUTERS/Aly Song
    Shanghai reopens some public transport, still on high Covid alert
  • Workers in protective suit spray disinfectant at a community, during the lockdown to curb the spread of the coronavirus disease (COVID-19) in Shanghai, China, April 5, 2022. REUTERS/Aly Song
    Dynamic zero-Covid approach: China's choice to safeguard lives, underpin growth
  • People wearing protective face masks walk on a street, following new cases of the coronavirus disease (Covid-19), in Shanghai, China August 25, 2021. REUTERS/Aly Song
    Shanghai district to require all shops to shut, residents to stay home
  • Photo: Courtesy
    Covax calls for urgent action to close vaccine equity gap
  • Photo: BSS/AFP
    Covax calls for urgent action to close vaccine equity gap
  • Photo: Collected
    Thousands of Covid-negative Beijing residents sent to quarantine

Related News

  • Dynamic zero-Covid approach: China's choice to safeguard lives, underpin economic growth
  • Covax calls for urgent action to close vaccine equity gap
  • Thousands of Covid-negative Beijing residents sent to quarantine
  • Shanghai inches towards Covid lockdown exit, Beijing plays defence
  • N Korea reports over 200,000 fever cases for 5th day amid Covid wave

Features

Other platform giants are dabbling with ways to copy TikTok. Photo: Bloomberg

Why everybody wants to be like TikTok

1h | Panorama
Illustration: TBS

How the ban on porn sites spawned a local cybersex industry

4h | Panorama
3 best affordable sunscreens for all

3 best affordable sunscreens for all

4h | Mode
Warah uses three types of khadi material: a sheer and light one, a medium count and a thicker one.

Warah: Embroidered with culture and womanhood

6h | Mode

More Videos from TBS

CV or Resume: Which one to create for job application

CV or Resume: Which one to create for job application

5h | Videos
Wheat prices double in India

Wheat prices double in India

19h | Videos
Is Washington-Moscow agreement possible?

Is Washington-Moscow agreement possible?

20h | Videos
Pigeon exhibition for the first time in Gazipur

Pigeon exhibition for the first time in Gazipur

1d | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

3
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

4
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

5
BSEC launches probe against Abul Khayer Hero and allies
Stocks

BSEC launches probe against Abul Khayer Hero and allies

6
The reception is a volumetric box-shaped room that has two glass walls on both the front and back ends and the other two walls are adorned with interior plants, wood and aluminium screens. Photo: Noor-A-Alam
Habitat

The United House: Living and working inside nature

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab